CLASS I Drug recall · Reported 23 Feb 2022 · FDA Enforcement Report

RED Mammoth capsules, 400 mg recalled by Celebrate Today

Celebrate Today is recalling RED Mammoth capsules, 400 mg, distributed nationwide in the US. The recall was initiated on 8 Feb 2022 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot # DK1027, Exp. 08/01/2023
Quantity recalled500 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0638-2022
FDA event ID
89563
Recalling firm
Celebrate Today, Brentwood, NY
Classification
Class I
Status
Terminated
Recall initiated
8 Feb 2022
FDA classified
28 Feb 2022
Reported
23 Feb 2022
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Labeling Errors

Timeline

8 Feb 2022Recall initiated by company
23 Feb 2022Published in enforcement report+15 days
28 Feb 2022Classified by FDA+5 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Product as listed by the FDA

RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.

Where it was distributed

Product was distributed nationwide in the USA via Amazon Marketplace

Nationwide

Stores named: Amazon

Questions about this recall

Is RED Mammoth capsules, 400 mg recalled?

Yes. Celebrate Today recalled RED Mammoth capsules, 400 mg on 8 Feb 2022. The recall is Class I and its status is Terminated. Recall number D-0638-2022.

Why was it recalled?

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Which lots are affected?

Lot # DK1027, Exp. 08/01/2023

Where was it sold?

Product was distributed nationwide in the USA via Amazon Marketplace

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.